Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences between plasma and serum complement in patients with chronic liver disease

S Inai, H Kitamura, T Fujita

    Clinical and Experimental Immunology
    |September 1, 1976
    PubMed
    Summary

    Chronic liver disease patients with cirrhosis showed low serum complement levels (CH50), indicating early complement component activation during blood coagulation. This finding was specific to serum, not plasma, in these patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Trends in research on social cognition: studies of organization of person information and knowledge activation].

    Shinrigaku kenkyu : The Japanese journal of psychology·2000
    Same author

    Interleukin-4-dependent induction of preproenkephalin in antigen-specific T helper-type 2 (Th2) cells.

    Journal of neuroimmunology·2000
    Same author

    Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes.

    The Journal of pharmacology and experimental therapeutics·2000
    Same author

    Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes.

    Journal of biochemistry·2000
    Same author

    Unilateral pulmonary cystic enlargement in a newborn: remember the one-sided blind intubation.

    Paediatric anaesthesia·2000
    Same author

    Sonographic detection of visceral adhesion in percutaneous drainage of afferent-loop small-intestine obstruction.

    Journal of clinical ultrasound : JCU·2000

    Area of Science:

    • Immunology
    • Hepatology
    • Biochemistry

    Background:

    • Chronic liver disease, including cirrhosis and chronic hepatitis, can affect immune system function.
    • The complement system is a crucial part of innate immunity, involving a cascade of proteins.

    Purpose of the Study:

    • To investigate complement component levels in patients with chronic liver disease.
    • To explore potential differences between serum and plasma complement activity in this patient group.

    Main Methods:

    • Serum and plasma total complement activity (CH50) were measured.
    • Complement component profiles, including C2, C3, C4, and C3-C9, were analyzed in patients with low serum CH50.
    • Patients with hepatitis B surface antigen were also assessed for CH50 differences.

    Related Experiment Videos

    Main Results:

    • Eight out of sixty chronic liver disease patients with cirrhosis or chronic hepatitis exhibited significantly low serum CH50 but normal plasma CH50.
    • These patients displayed markedly decreased C4 and C2 complement activities, with normal C3-C9 activities.
    • No significant difference in serum versus plasma CH50 was observed in patients with hepatitis B surface antigen.

    Conclusions:

    • Early-acting complement components (C4, C2) may be non-specifically activated during blood coagulation in some chronic liver disease patients.
    • Serum CH50 levels can be a more sensitive indicator than plasma CH50 in specific chronic liver disease contexts.
    • Further research is needed to elucidate the precise mechanisms of complement activation in chronic liver disease.